{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,16]],"date-time":"2026-09-16T22:10:00Z","timestamp":1789596600454,"version":"build-2803163510"},"reference-count":30,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2019,4,29]],"date-time":"2019-04-29T00:00:00Z","timestamp":1556496000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"},{"start":{"date-parts":[[2019,4,29]],"date-time":"2019-04-29T00:00:00Z","timestamp":1556496000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"Cancer Biology Training Grant","award":["CBTG T32CA198808"],"award-info":[{"award-number":["CBTG T32CA198808"]}]},{"DOI":"10.13039\/100000005","name":"U.S. Department of Defense","doi-asserted-by":"publisher","award":["BC133808"],"award-info":[{"award-number":["BC133808"]}],"id":[{"id":"10.13039\/100000005","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000048","name":"American Cancer Society","doi-asserted-by":"publisher","award":["RSG-CCG-122517"],"award-info":[{"award-number":["RSG-CCG-122517"]}],"id":[{"id":"10.13039\/100000048","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000054","name":"National Cancer Institute","doi-asserted-by":"crossref","award":["NCI-R21-CA198808"],"award-info":[{"award-number":["NCI-R21-CA198808"]}],"id":[{"id":"10.13039\/100000054","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/100000054","name":"National Cancer Institute","doi-asserted-by":"crossref","award":["NCI-R21-CA198808"],"award-info":[{"award-number":["NCI-R21-CA198808"]}],"id":[{"id":"10.13039\/100000054","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/100008533","name":"Case Comprehensive Cancer Center, Case Western Reserve University","doi-asserted-by":"publisher","award":["P30CA43703"],"award-info":[{"award-number":["P30CA43703"]}],"id":[{"id":"10.13039\/100008533","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Breast Cancer Res"],"published-print":{"date-parts":[[2019,12]]},"DOI":"10.1186\/s13058-019-1136-x","type":"journal-article","created":{"date-parts":[[2019,4,29]],"date-time":"2019-04-29T13:29:58Z","timestamp":1556544598000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":75,"title":["The opposing effects of interferon-beta and oncostatin-M as regulators of cancer stem cell plasticity in triple-negative breast cancer"],"prefix":"10.1186","volume":"21","author":[{"given":"Mary R.","family":"Doherty","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jenny G.","family":"Parvani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ilaria","family":"Tamagno","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Damian J.","family":"Junk","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Benjamin L.","family":"Bryson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hyeon Joo","family":"Cheon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"George R.","family":"Stark","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mark W.","family":"Jackson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2019,4,29]]},"reference":[{"key":"1136_CR1","doi-asserted-by":"publisher","first-page":"4429","DOI":"10.1158\/1078-0432.CCR-06-3045","volume":"13","author":"R Dent","year":"2007","unstructured":"Dent R, Trudeau M, Pritchard KI, Hanna WM, Kahn HK, Sawka CA, et al. Triple-negative breast cancer: clinical features and patterns of recurrence. Clin Cancer Res. 2007;13:4429\u201334.","journal-title":"Clin Cancer Res"},{"issue":"9","key":"1136_CR2","doi-asserted-by":"publisher","first-page":"e43110","DOI":"10.1371\/journal.pone.0043110","volume":"7","author":"G Perrone","year":"2012","unstructured":"Perrone G, Gaeta LM, Zagami M, Nasorri F, Coppola R, Borzomati D, et al. In situ identification of CD44+\/CD24- cancer cells in primary human breast carcinomas. PLoS One. 2012;7(9):e43110.","journal-title":"PLoS One"},{"issue":"3","key":"1136_CR3","doi-asserted-by":"publisher","first-page":"1348","DOI":"10.1172\/JCI65416","volume":"123","author":"NE Bhola","year":"2013","unstructured":"Bhola NE, Balko JM, Dugger TC, Kuba MG, Sanchez V, Sanders M, et al. TGF-beta inhibition enhances chemotherapy action against triple-negative breast cancer. J Clin Invest. 2013;123(3):1348\u201358.","journal-title":"J Clin Invest"},{"key":"1136_CR4","doi-asserted-by":"publisher","first-page":"4001","DOI":"10.1038\/onc.2017.33","volume":"36","author":"DJ Junk","year":"2017","unstructured":"Junk DJ, Bryson BL, Smigiel JM, Parameswaran N, Bartel CA, Jackson MW. Oncostatin M promotes cancer cell plasticity through cooperative STAT3-SMAD3 signaling. Oncogene. 2017;36:4001\u201313.","journal-title":"Oncogene."},{"issue":"3","key":"1136_CR5","doi-asserted-by":"publisher","first-page":"159","DOI":"10.1016\/S0165-2478(98)00040-6","volume":"62","author":"RA Singh","year":"1998","unstructured":"Singh RA, Sodhi A. Cisplatin-treated macrophages produce oncostatin M: regulation by serine\/threonine and protein tyrosine kinases\/phosphatases and Ca2+\/calmodulin. Immunol Lett. 1998;62(3):159\u201364.","journal-title":"Immunol Lett"},{"issue":"23","key":"1136_CR6","doi-asserted-by":"publisher","first-page":"6806","DOI":"10.1158\/0008-5472.CAN-14-0160","volume":"74","author":"L Lapeire","year":"2014","unstructured":"Lapeire L, Hendrix A, Lambein K, Van Bockstal M, Braems G, Van Den Broecke R, et al. Cancer-associated adipose tissue promotes breast cancer progression by paracrine oncostatin M and Jak\/STAT3 signaling. Cancer Res. 2014;74(23):6806\u201319.","journal-title":"Cancer Res"},{"issue":"22","key":"1136_CR7","doi-asserted-by":"publisher","first-page":"10891","DOI":"10.1158\/0008-5472.CAN-06-1766","volume":"66","author":"N Underhill-Day","year":"2006","unstructured":"Underhill-Day N, Heath JK. Oncostatin M (OSM) cytostasis of breast tumor cells: characterization of an OSM receptor beta-specific kernel. Cancer Res. 2006;66(22):10891\u2013901.","journal-title":"Cancer Res"},{"issue":"2","key":"1136_CR8","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1007\/s12079-012-0186-y","volume":"7","author":"G Dey","year":"2013","unstructured":"Dey G, Radhakrishnan A, Syed N, Thomas JK, Nadig A, Srikumar K, et al. Signaling network of Oncostatin M pathway. J Cell Commun Signal. 2013;7(2):103\u20138.","journal-title":"J Cell Commun Signal"},{"key":"1136_CR9","doi-asserted-by":"publisher","first-page":"1688","DOI":"10.1158\/1078-0432.CCR-14-0432","volume":"21","author":"MD Burstein","year":"2015","unstructured":"Burstein MD, Tsimelzon A, Poage GM, Covington KR, Contreras A, Fugua SA, et al. Comprehensive genomic analysis identifies novel subtypes and targets of triple-negative breast cancer. Clin Cancer Res. 2015;21:1688\u201398.","journal-title":"Clin Cancer Res"},{"key":"1136_CR10","doi-asserted-by":"publisher","first-page":"1224","DOI":"10.1038\/nm.2830","volume":"18","author":"BN Bidwell","year":"2012","unstructured":"Bidwell BN, Slaney CY, Withana NP, Forster S, Cao Y, Loi S, et al. Silencing of Irf7 pathways in breast cancer cells promotes bone metastasis through immune escape. Nat Med. 2012;18:1224\u201331.","journal-title":"Nat Med"},{"key":"1136_CR11","doi-asserted-by":"publisher","first-page":"R48","DOI":"10.1186\/bcr3148","volume":"14","author":"S Liu","year":"2012","unstructured":"Liu S, Lachapelle J, Leung S, Gao D, Foulkes WD, Nielsen TO. CD8+ lymphocyte infiltration is an independent favorable prognostic indicator in basal-like breast cancer. Breast Cancer Res. 2012;14:R48.","journal-title":"Breast Cancer Res"},{"issue":"52","key":"1136_CR12","doi-asserted-by":"publisher","first-page":"13792","DOI":"10.1073\/pnas.1713728114","volume":"114","author":"MR Doherty","year":"2017","unstructured":"Doherty MR, Cheon H, Junk DJ, Vinayak S, Varadan V, Telli ML, et al. Interferon-beta represses cancer stem cell properties in triple-negative breast cancer. Proc Natl Acad Sci. 2017;114(52):13792\u20137.","journal-title":"Proc Natl Acad Sci"},{"key":"1136_CR13","doi-asserted-by":"publisher","first-page":"18490","DOI":"10.1073\/pnas.0809242105","volume":"105","author":"RR Weichselbaum","year":"2008","unstructured":"Weichselbaum RR, Ishwaran H, Yoon T, Nuyten DSA, Baker SW, Khodarev N, et al. An interferon-related gene signature for DNA damage resistance is a predictive marker for chemotherapy and radiation for breast cancer. Proc Natl Acad Sci. 2008;105:18490\u20135.","journal-title":"Proc Natl Acad Sci"},{"key":"1136_CR14","doi-asserted-by":"publisher","first-page":"2751","DOI":"10.1038\/emboj.2013.203","volume":"32","author":"H Cheon","year":"2013","unstructured":"Cheon H, Holvey-Bates EG, Schoggins JW, Forster S, Hertzog P, Imanaka N, et al. IFN-\u03b2-independent increases in STAT1, STAT2, and IRF9 mediate resistance to viruses and DNA damage. EMBO J. 2013;32:2751\u201363.","journal-title":"EMBO J"},{"key":"1136_CR15","doi-asserted-by":"publisher","first-page":"9373","DOI":"10.1073\/pnas.0903487106","volume":"106","author":"H Cheon","year":"2009","unstructured":"Cheon H, Stark GR. Unphosphorylated STAT1 prolongs the expression of interferon-induced immune regulatory genes. Proc Natl Acad Sci. 2009;106:9373\u20138.","journal-title":"Proc Natl Acad Sci"},{"key":"1136_CR16","doi-asserted-by":"publisher","first-page":"1100","DOI":"10.1593\/neo.131114","volume":"15","author":"DJ Junk","year":"2013","unstructured":"Junk DJ, Cipriano R, Bryson BL, Gilmore HL, Jackson MW. Tumor microenvironmental signaling elicits epithelial-mesenchymal plasticity through cooperation with transforming genetic events. Neoplasia. 2013;15:1100\u20139.","journal-title":"Neoplasia."},{"key":"1136_CR17","doi-asserted-by":"publisher","first-page":"2750","DOI":"10.1172\/JCI45014","volume":"121","author":"BD Lehman","year":"2011","unstructured":"Lehman BD, Bauer JA, Xi C, Sanders ME, Chakravarthy AB, Shyr Y, et al. Identification of human triple-negative breast cancer subtypes and preclinical models for selection of targeted therapies. J Clin Invest. 2011;121:2750\u201367.","journal-title":"J Clin Invest"},{"issue":"2","key":"1136_CR18","doi-asserted-by":"publisher","first-page":"295","DOI":"10.1016\/j.jhep.2006.09.014","volume":"46","author":"H Weng","year":"2007","unstructured":"Weng H, Mertens PR, Gressner AM, Dooley S, et al. IFN-gamma abrogates profibrogenic TGF-beta signaling in liver by targeting expression of inhibitory and receptor smads. J Hepatol. 2007;46(2):295\u2013303.","journal-title":"J Hepatol"},{"key":"1136_CR19","doi-asserted-by":"publisher","first-page":"14228","DOI":"10.1038\/ncomms14228","volume":"8","author":"Y Wu","year":"2017","unstructured":"Wu Y, Wang Y, Lin Y, Liu Y, Wang Y, Jia J, et al. Dub3 inhibition suppresses breast cancer invasion and metastasis by promoting snail1 degradation. Nat Commun. 2017;8:14228.","journal-title":"Nat Commun"},{"issue":"3","key":"1136_CR20","doi-asserted-by":"publisher","first-page":"1411","DOI":"10.1128\/MCB.24.3.1411-1425.2004","volume":"24","author":"J Qing","year":"2004","unstructured":"Qing J, Liu C, Choy L, Wu RY, Pagano JS, Derynck R. Transforming growth factor beta\/smad3 signaling regulates IRF-7 function and transcriptional activation of the beta interferon promoter. Mol Cell Biol. 2004;24(3):1411\u201325.","journal-title":"Mol Cell Biol"},{"key":"1136_CR21","doi-asserted-by":"publisher","first-page":"131","DOI":"10.1038\/nrc.2016.14","volume":"16","author":"BS Parker","year":"2016","unstructured":"Parker BS, Rautela J, Hertzog PJ. Anti-tumor actions of interferons: implications for cancer therapy. Nat Rev Cancer. 2016;16:131\u201344.","journal-title":"Nat Rev Cancer"},{"key":"1136_CR22","doi-asserted-by":"publisher","first-page":"1301","DOI":"10.1038\/nm.3708","volume":"20","author":"A Sistigu","year":"2014","unstructured":"Sistigu A, Yamazaki T, Vacchelli E, Chaba K, Enot DP, Adam J, et al. Cancer cell-autonomous contribution of type I interferon signaling to the efficacy of chemotherapy. Nat Med. 2014;20:1301\u20139.","journal-title":"Nat Med"},{"issue":"5","key":"1136_CR23","doi-asserted-by":"publisher","first-page":"492","DOI":"10.1038\/icb.1997.76","volume":"75","author":"A Sodhi","year":"1997","unstructured":"Sodhi A, Shishodia S, Shrivastava A. Cisplatin-stimulated murine bone marrow-derived macrophages secrete oncostatin M. Immunol Cell Biol. 1997;75(5):492\u20136.","journal-title":"Immunol Cell Biol"},{"key":"1136_CR24","doi-asserted-by":"publisher","first-page":"512103","DOI":"10.1155\/2013\/512103","volume":"2013","author":"CD Richards","year":"2013","unstructured":"Richards CD. The enigmatic cytokine oncostatin m and roles in disease. ISRN Inflamm. 2013;2013:512103.","journal-title":"ISRN Inflamm"},{"issue":"45","key":"1136_CR25","doi-asserted-by":"publisher","first-page":"5272","DOI":"10.1038\/onc.2012.573","volume":"32","author":"L Guo","year":"2013","unstructured":"Guo L, Chen C, Shi M, Wang F, Chen X, Diao D, et al. Stat3-coordinated Lin-28-let-7-HMGA2 and miR-200-ZEB1 circuits initiate and maintain oncostatin M-driven epithelial-mesenchymal transition. Oncogene. 2013;32(45):5272\u201382.","journal-title":"Oncogene."},{"key":"1136_CR26","doi-asserted-by":"publisher","first-page":"904","DOI":"10.1038\/nature07815","volume":"458","author":"MA Essers","year":"2009","unstructured":"Essers MA, Offner S, Blanco-Bose WE, Waibler Z, Kalinke U, Duchosal MA, et al. IFNalpha activates dormant haematopoietic stem cells in vivo. Nature. 2009;458:904\u20138.","journal-title":"Nature."},{"key":"1136_CR27","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1007\/s12307-010-0041-8","volume":"3","author":"X Ling","year":"2010","unstructured":"Ling X, Marini F, Konopleva M, Schober W, Shi Y, Burks J, et al. Mesenchymal stem cells overexpressing interferon-\u03b2 inhibit breast cancer growth and metastases through stat3 signaling in a syngeneic tumor model. Cancer Microenviron. 2010;3:83\u201395.","journal-title":"Cancer Microenviron"},{"issue":"1","key":"1136_CR28","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1016\/j.ccr.2013.12.004","volume":"25","author":"X Yang","year":"2014","unstructured":"Yang X, Zhang X, Fu ML, Weichselbaum RR, Gajewski TF, Guo Y, et al. Targeting the tumor microenvironment with interferon-\u03b2 bridges innate and adaptive immune responses. Cancer Cell. 2014;25(1):37\u201348.","journal-title":"Cancer Cell"},{"issue":"2","key":"1136_CR29","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1177\/1947601912458284","volume":"3","author":"C Bolin","year":"2012","unstructured":"Bolin C, Tawara K, Sutherland C, Redshaw J, Aranda P, Moselhy J, et al. Oncostatin m promotes mammary tumor metastasis to bone and osteolytic bone degradation. Genes Cancer. 2012;3(2):117\u201330.","journal-title":"Genes Cancer"},{"issue":"7","key":"1136_CR30","doi-asserted-by":"publisher","first-page":"1076","DOI":"10.1016\/j.drudis.2016.04.003","volume":"21","author":"S Steeland","year":"2016","unstructured":"Steeland S, Vandenbroucke RE, Libert C. Nanobodies as therapeutics: big opportunities for small antibodies. Drug Discov Today. 2016;21(7):1076\u2013113.","journal-title":"Drug Discov Today"}],"container-title":["Breast Cancer Research"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s13058-019-1136-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/s13058-019-1136-x\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s13058-019-1136-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,5,15]],"date-time":"2020-05-15T13:10:38Z","timestamp":1589548238000},"score":1,"resource":{"primary":{"URL":"https:\/\/breast-cancer-research.biomedcentral.com\/articles\/10.1186\/s13058-019-1136-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,4,29]]},"references-count":30,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2019,12]]}},"alternative-id":["1136"],"URL":"https:\/\/doi.org\/10.1186\/s13058-019-1136-x","relation":{},"ISSN":["1465-542X"],"issn-type":[{"value":"1465-542X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,4,29]]},"assertion":[{"value":"27 September 2018","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 April 2019","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 April 2019","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Experiments involving animals were performed in compliance with the guidelines approved by the Case Western Reserve University Institutional Animal Care and Use Committee (IACUC).","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Publisher\u2019s Note"}}],"article-number":"54"}}